Helapet has announced that it has entered into a new sales agreement with UK isolator manufacture Cirrus Containments. Enhancing Helapet’s extensive product portfolio, clients are now offered a complete containment solution with new tailor-designed isolator units.
Cirrus Containments' aseptic isolators create a reliable, ultra-sterile environment through the use of superior barrier isolation technology that provides excellent levels of protection for the product and the operator. Each isolator is purpose-designed and built to meet the diverse requirements of isolator users including hospital pharmacy, pharmaceutical manufacturers and nuclear medicine.
Ergonomically designed to minimise space and modular constructed to meet the specific needs of the client, Cirrus Containments' isolators maintain high standards of user safety whilst minimising the risk of fatigue or discomfort.
John Blight, Managing Director of Helapet comments: “The welcome addition of Cirrus Containments' isolators to our growing line of specialist containment products means our customers can expect an increasingly comprehensive range of solutions to help reduce the risk of product and user contamination in the workplace."
